IPCALAB.NS

Ipca Laboratories Limited IPCALAB.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IPCALAB.NS AJANTPHARM.BO AJANTPHARM.NS COHANCE.BO COHANCE.NS GLAND.NS GLAND.BO JBCHEPHARM.NS JBCHEPHARM.BO PEL.NS
6M -10.01 % -8.38 % -8.64 % -25.46 % -25.28 % 31.28 % 31.43 % 1.94 % 2.45 % 8.11 %
YTD -24.32 % -18.28 % -18.26 % -19.95 % -19.97 % 6.21 % 6.33 % -9.98 % -9.87 % 2.70 %
1Y -20.63 % -21.86 % -22.06 % -29.47 % -29.64 % 14.76 % 14.78 % -11.29 % -11.17 % 8.98 %
3Y 41.76 % 99.42 % 98.61 % 121.82 % 122.19 % -12.22 % -11.92 % 70.51 % 71.46 % 32.59 %
5Y 23.45 % 129.44 % 128.98 % 163.22 % 162.81 % 5.66 % 5.71 % 65.44 % 229.60 % 55.90 %
10Y 238.74 % 134.60 % 133.80 % 435.54 % 433.04 % 5.66 % 5.71 % 462.85 % 1 025.01 % 126.06 %
From the beginning 13 677.42 % 15 236.56 % 15 529.63 % 435.54 % 433.04 % 5.66 % 5.71 % 7 309.29 % 82 858.33 % 4 306.90 %

Dividend

Ipca Laboratories Limited

Ajanta Pharma Limited

Ajanta Pharma Limited

Cohance Lifesciences Limited

Cohance Lifesciences Limited

Gland Pharma Limited

Gland Pharma Limited

J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

Piramal Enterprises Limited